PLAUR and neoplasm: Penetrating tumour cells focus on the proteolytic activity of the serine protease urokinase-type plasminogen activator (uPA) secreted by tumour cells or surrounding stromal cells to the cell surface through a receptor for uPA (uPAR, CD87), thus facilitating extracellular matrix degradation.